Literature DB >> 7272207

Reduction of increased polyamine levels in psoriatic lesions by retinoid and PUVA treatments.

J Lauharanta, M Kousa, K Kapyaho, K Linnamaa, K Mustakallio.   

Abstract

Treatment with an oral aromatic retinoid (etretinate) and with PUVA significantly reduced the elevated levels of putrescine, spermidine and spermine in psoriatic lesions. Both treatments also significantly reduced the spermidine/spermine ratio, which is considered to be an indicator of proliferation activity. Although both regimens produced a roughly parallel reduction of epidermal polyamines the initial fall of putrescine was much more rapid in patients receiving retinoid. This may indicate that one of the primary targets of retinoids could be ornithine decarboxylase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272207     DOI: 10.1111/j.1365-2133.1981.tb01284.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

2.  N1N8-bis(gamma-glutamyl)spermidine cross-linking in epidermal-cell envelopes. Comparison of cross-link levels in normal and psoriatic cell envelopes.

Authors:  N Martinet; S Beninati; T P Nigra; J E Folk
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

3.  Response of epidermal polyamines to orally administered aromatic retinoid RO 10-9359.

Authors:  P El Baze; G Milano; P Verrando; N Renee; J P Ortonne
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

4.  Polyamine levels in normal human skin. A comparative study of pure epidermis, pure dermis, and suction blister fluid.

Authors:  P El Baze; G Milano; P Verrando; N Renée; J P Ortonne
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 5.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

6.  Polyamine metabolism changes in psoriasis.

Authors:  Valentina Broshtilova; Valentina Lozanov; Ljubka Miteva
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.